Ceribell, Inc. (CBLL) Stock Research

Today

Ceribell raises FY26 revenue view to $114M-$117M from $112M-$116M

CBLL

4:53 PM

Ceribell reports Q2 EPS (51c), consensus (46c)

CBLL

4:50 PM

Ceribell announces FDA clearance for two new AI algorithm enhancements

CBLL

7:03 AM

Over a week ago

Ceribell secures CMS NTAP for Delirium Monitor System

CBLL

Aug 3, 7:48 AM

Ceribell price target lowered by $3 at Canaccord, here's why

CBLL

May 12, 6:35 AM

Ceribell sees FY26 revenue $112M-$116M, consensus $113.18M

CBLL

May 11, 4:09 PM

Ceribell reports Q1 EPS (52c), consensus (39c)

CBLL

May 11, 4:09 PM

Ceribell receives 510(k) premarket notification for brain monitor headband

CBLL

Apr 7, 9:52 AM

Ceribell price target lowered by $2 at Canaccord, here's why

CBLL

Feb 25, 6:50 AM

Ceribell sees FY26 revenue $111M-$115M, consensus $112.67M

CBLL

Feb 24, 4:17 PM

Ceribell reports Q4 EPS (36c), consensus (41c)

CBLL

Feb 24, 4:17 PM

Ceribell receives FDA breakthrough device designation for LVO SD monitor

CBLL

Jan 5, 8:08 AM

Ceribell price target raised by $1 at Canaccord, here's why

CBLL

Dec 17, 7:18 AM

Ceribell price target raised by $9 at TD Cowen, here's why

CBLL

Dec 9, 11:06 AM

Ceribell receives FDA 510k clearance for delirium screening, monitoring device

CBLL

Dec 9, 8:06 AM

Ceribell management to meet virtually with BTIG

CBLL

Dec 2, 1:17 PM

Ceribell receives FDA 510(k) clearance for Clarity algorithm

CBLL

Nov 24, 8:02 AM

Ceribell price target lowered by $16 at TD Cowen, here's why

CBLL

Nov 5, 8:53 AM

Ceribell price target lowered by $4 at JPMorgan, here's why

CBLL

Nov 5, 7:42 AM

Ceribell raises FY25 revenue view to $87M-$89M from $85M-$88M

CBLL

Nov 4, 5:01 PM

Ceribell reports Q3 EPS (37c), consensus (41c)

CBLL

Nov 4, 4:57 PM

Ceribell files $300M mixed securities shelf

CBLL

Nov 4, 4:07 PM

Ceribell initiated with bullish view at Raymond James, here's why

CBLL

Oct 20, 4:13 PM

Ceribell appoints Erica Rogers to board of directors

CBLL

Sep 22, 8:24 AM

Today

Ceribell raises FY26 revenue view to $114M-$117M from $112M-$116M

CBLL

4:53 PM

Ceribell reports Q2 EPS (51c), consensus (46c)

CBLL

4:50 PM

Ceribell announces FDA clearance for two new AI algorithm enhancements

CBLL

7:03 AM

Over a week ago

Ceribell secures CMS NTAP for Delirium Monitor System

CBLL

Aug 3, 7:48 AM

Ceribell price target lowered by $3 at Canaccord, here's why

CBLL

May 12, 6:35 AM

Ceribell sees FY26 revenue $112M-$116M, consensus $113.18M

CBLL

May 11, 4:09 PM

Ceribell reports Q1 EPS (52c), consensus (39c)

CBLL

May 11, 4:09 PM

Ceribell receives 510(k) premarket notification for brain monitor headband

CBLL

Apr 7, 9:52 AM

Ceribell price target lowered by $2 at Canaccord, here's why

CBLL

Feb 25, 6:50 AM

Ceribell sees FY26 revenue $111M-$115M, consensus $112.67M

CBLL

Feb 24, 4:17 PM

Ceribell reports Q4 EPS (36c), consensus (41c)

CBLL

Feb 24, 4:17 PM

Ceribell receives FDA breakthrough device designation for LVO SD monitor

CBLL

Jan 5, 8:08 AM

Ceribell price target raised by $1 at Canaccord, here's why

CBLL

Dec 17, 7:18 AM

Ceribell price target raised by $9 at TD Cowen, here's why

CBLL

Dec 9, 11:06 AM

Ceribell receives FDA 510k clearance for delirium screening, monitoring device

CBLL

Dec 9, 8:06 AM

Ceribell management to meet virtually with BTIG

CBLL

Dec 2, 1:17 PM

Ceribell receives FDA 510(k) clearance for Clarity algorithm

CBLL

Nov 24, 8:02 AM

Ceribell price target lowered by $16 at TD Cowen, here's why

CBLL

Nov 5, 8:53 AM

Ceribell price target lowered by $4 at JPMorgan, here's why

CBLL

Nov 5, 7:42 AM

Ceribell raises FY25 revenue view to $87M-$89M from $85M-$88M

CBLL

Nov 4, 5:01 PM

Ceribell reports Q3 EPS (37c), consensus (41c)

CBLL

Nov 4, 4:57 PM

Ceribell files $300M mixed securities shelf

CBLL

Nov 4, 4:07 PM

Ceribell initiated with bullish view at Raymond James, here's why

CBLL

Oct 20, 4:13 PM

Ceribell appoints Erica Rogers to board of directors

CBLL

Sep 22, 8:24 AM

Company News

Charts